INDSWIFT LABORATORIES
|
The Current P/E Ratio of INDSWIFT LABORATORIES is 3.80.
| Share Price | ₹111.3 | Jan 19,2026 |
| Market Cap | ₹907.8 Cr | |
| Earnings-TTM | ₹239.0 Cr | TTM-Consolidated Results |
| Price/Earnings | 3.80x | Calculated as Market Cap/Earnings |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PE (Price/Earnings) ratio of INDSWIFT LABORATORIES
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹907.8 Cr] as on Jan 19,2026
(/) Earnings [ ₹239.0 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 3.80x ]
Thus, for INDSWIFT LABORATORIES , the investors are currently willing to pay 3.80 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of INDSWIFT LABORATORIES !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of INDSWIFT LABORATORIES over the last five years.
Historical PE (Price/Earnings) ratio chart of INDSWIFT LABORATORIES
PE Ratio Performance Analysis for INDSWIFT LABORATORIES
- INDSWIFT LABORATORIES 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 2.11x.
- INDSWIFT LABORATORIES 's operated at median p/e ratio of 1.38x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, INDSWIFT LABORATORIES 's p/e ratio peaked in Mar2023 at 6.86x.
- INDSWIFT LABORATORIES 's p/e ratio hit its five-year low in Mar2022 of 0x.
How does INDSWIFT LABORATORIES 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
|---|---|---|---|
| INDSWIFT LABORATORIES | 238.96 | 3.80 | 907.8 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 10,517.90 | 38.18 | 401,541.0 |
| DIVIS LABORATORIES LTD | 2,485.00 | 65.61 | 163,031.0 |
| CIPLA LTD | 5,453.86 | 20.61 | 112,377.0 |
| TORRENT PHARMACEUTICALS LTD | 2,140.00 | 64.70 | 138,451.0 |
| DR REDDYS LABORATORIES LTD | 5,721.40 | 17.02 | 97,355.5 |
| MANKIND PHARMA LTD | 1,767.06 | 49.48 | 87,425.9 |
| ZYDUS LIFESCIENCES LTD | 4,973.40 | 17.83 | 88,659.3 |
| LUPIN LTD | 4,347.53 | 22.89 | 99,499.9 |
| AUROBINDO PHARMA LTD | 3,447.75 | 19.66 | 67,791.2 |
| ABBOTT INDIA LTD | 1,508.95 | 39.11 | 59,016.8 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs INDSWIFT LABORATORIES 's P/E Ratio
| Top 10 Industry Peers | PE Ratio |
|---|---|
| Min industry PE | 3.80x |
| Max industry PE | 65.61x |
| Median industry PE | 22.89x |
| Average industry PE | 32.62x |
You may also like the below Video Courses